[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340337-105":59,"doc-detail-340337-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","current-status-of-the-prediction-for-radio-iodine-refractory-thyroid-cancer-a-narrative-review","Current status of the prediction for radio-iodine refractory thyroid cancer - a narrative review","","Radio-iodine refractory thyroid cancer (RAIR) is associated with poor prognosis and low 10-year survival, while current therapeutic options remain limited and often ineffective. This narrative review summarizes recent developments in predictive modeling for RAIR occurrence. Demographic factors, tumor clinicopathological features, serological changes, disease characteristics, and PET/CT findings have been reported as independent predictors. Multivariate model cut-off values may estimate RAIR onset, but most evidence comes from retrospective studies, requiring future prospective validation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/current-status-of-the-prediction-for-radio-iodine-refractory-thyroid-cancer-a-narrative-review/340337/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/current-status-of-the-prediction-for-radio-iodine-refractory-thyroid-cancer-a-narrative-review/340337.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is radio-iodine refractory thyroid cancer associated with a poor prognosis?","Question",{"text":112,"@type":113},"When differentiated thyroid cancer progresses to radio-iodine refractory thyroid cancer, radio-iodine uptake by recurrent or metastatic lesions decreases, leading to rapid disease progression and low long-term survival.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What kinds of variables have been reported as independent predictors of RAIR?",{"text":117,"@type":113},"Reported independent predictors include demographic characteristics, tumor clinicopathology, serology changes, disease characteristics, and PET/CT results.",{"name":119,"@type":110,"acceptedAnswer":120},"How are RAIR prediction models evaluated for clinical relevance?",{"text":121,"@type":113},"Multivariate prediction models produce cut-off values derived from retrospective studies that can effectively predict RAIR onset, but prospective studies are needed to confirm validity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340337,1790254064,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Mini Review  \nPUBLISHED 15 October 2024  \nDOI 10.3389/fendo.2024.1433553  \nOPEN ACCESS  \nEDITED BY  \nVincenzo Marotta,  \nAOU S. Giovanni di Dio e Ruggi D’Aragona, Italy  \nREVIEWED BY  \nAlexandra Chera,  \nCarol Davila University of Medicine and Pharmacy, Romania  \nFl´avia Dornelas Kurkowski,  \nPontiﬁcal Catholic University of Rio Grande do Sul, Brazil  \nDiego Bromfman Pianta,  \nPontiﬁcal Catholic University of Rio Grande do Sul, Brazil  \n*CORRESPONDENCE  \nHaiyan Liu  \n [liuhaiyan-1203@126.com](liuhaiyan-1203@126.com)  \nRECEIVED 16 May 2024  \nACCEPTED 30 September 2024  \nPUBLISHED 15 October 2024  \nCITATION  \nWang Y, Lu X and Liu H (2024) Current status of the prediction for radio-iodine refractory thyroid cancer: a narrative review.  \nFront. Endocrinol. 15:1433553 .  \ndoi: 10.3389/fendo.2024.1433553  \nCOPYRIGHT  \n© 2024 Wang, Lu and Liu. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nCurrent status of the prediction for radio-iodine refractory thyroid cancer: a  \nnarrative review  \nYuhua Wang 1,2, Xiurong Lu 1,3 and Haiyan Liu 1,4,5*  \n1 Department of Nuclear Medicine, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China, 2 Department of Nuclear Medicine, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, China, 3 Department of Nuclear Medicine, Linfen Central Hospital of Shanxi Province, Linfen, Shanxi, China, 4Shanxi Key Laboratory of Molecular Imaging, Shanxi Medical University, Taiyuan, Shanxi, China, 5Collaborative Innovation Center for Molecular Imaging of Precision Medicine Shanxi Medical University, Taiyuan, Shanxi, China  \nIt is well established that patients with the most differentiated thyroid cancers have a good prognosis, whereas when the disease develops into radio-iodine refractory thyroid cancer (RAIR) their prognosis is poor and the 10-year survival rate is low. At present, the therapeutic methods for RAIR are limited and have low efﬁcacy. As a consequence, several models have been developed for predicting RAIR. The aim of this review was to describe recent developments regarding the factors that inﬂuence and predict the occurrence of RAIR. Many variables including demographic characteristics, tumor clinicopathology, serology changes, disease characteristics, and PET/CT results have been shown to be independent factors that inﬂuence the development of RAIR. The cut-off value derived from multivariate prediction models therefore effectively predicts the onset of RAIR. However, the current models for predicting RAIR were obtained through retrospective studies, and the prospective prediction studies are needed in the future to conﬁrm their validity.  \nKEYWORDS  \nradio-iodine refractory, differentiated thyroid cancer, prediction, radioactive iodine therapy, PET/CT  \nIntroduction  \nThe global incidence of thyroid cancer, the most common malignancy in the endocrine system, has continued to rise in recent years (1) . The majority of thyroid cancers originate from follicular epithelial cells, with differentiated thyroid cancer (DTC) accounting for about 90% of lesions. DTC retains some of the physiological functions of thyroid follicular epithelial cells, such as the expression of the sodium iodine transporter (NIS) and the capacity to uptake iodine. As a consequence of these actions, most DTCs are sensitive to  \nFrontiers in Endocrinology 01 [frontiersin.org](frontiersin.org)  \nradioactive iodine (RAI) and can be cured by surgery, radioactive iodine therapy, and thyroid hormone sup","cbCaibVno2jYNr22","https://ap.wps.com/l/cbCaibVno2jYNr22","pdf",405336,"English","# Introduction\n## Predictive factors and model performance\n## Need for prospective studies","[{\"question\":\"Why is radio-iodine refractory thyroid cancer associated with a poor prognosis?\",\"answer\":\"When differentiated thyroid cancer progresses to radio-iodine refractory thyroid cancer, radio-iodine uptake by recurrent or metastatic lesions decreases, leading to rapid disease progression and low long-term survival.\"},{\"question\":\"What kinds of variables have been reported as independent predictors of RAIR?\",\"answer\":\"Reported independent predictors include demographic characteristics, tumor clinicopathology, serology changes, disease characteristics, and PET/CT results.\"},{\"question\":\"How are RAIR prediction models evaluated for clinical relevance?\",\"answer\":\"Multivariate prediction models produce cut-off values derived from retrospective studies that can effectively predict RAIR onset, but prospective studies are needed to confirm validity.\"}]","Current status of the prediction for radio-iodine refractory thyroid cancer - a narrative review | PDF",1790035911,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a043946268a756a781a025aa9446bc9f.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1753d55eddf8087e57f32ac8510fbd76.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9102c6784c7bd1b2c4e9c859989f45de.webp",981,1386,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/895d290257d6a929f4d47a786a707d3d.webp",980,1385]